HIV positives demonstrated against di - iasociety.org

16 – 30 September 2009

South African HIV activists come out on the streets
Modern Ghana.com – Wed, 16 Sep 2009 11:17
Have Your say From Darhoon Menghwar, Journalist Pakistan CAPE TOWN - Thousands of people including
HIV positives demonstrated against discrimination at the opening ceremony of the International Aids Society
(IAS) conference here.
...positives demonstrated against discrimination at the opening ceremony of the International Aids Society
(IAS) conference here. The protest was...

Nutricia announces positive results in a trial targeting immune system in HIV patients
Pharmabiz – Wed, 16 Sep 2009 14:38
Nutricia Advanced Medical Nutrition has announced the results of a clinical trial targeting immunity in HIV
patients with a specific nutritional concept, NR100157.
...(ICAAC), by professor Pedro Cahn, former chair of the International AIDS Society. HIV affects 34 million
people worldwide today with more than...

HIV/AIDS, growth and poverty in KwaZulu-Natal and South Africa:an integrated survey, demographic
and economywide analysis
7thSpace – Wed, 16 Sep 2009 15:05
This paper estimates the economic impact of HIV/AIDS on the KwaZulu-Natal province and the rest of South
Africa. Methods: We extended previous studies by employing: an integrated analytical framework that
combined firm surveys of workers'HIV prevalence by sector and occupation; a demographic model that
produced both population and workforce projections; and a regionalized economy-wide model linked to a
survey-based micro-simulation module.
...economic costs of the pandemic. Author: James ThurlowJeff GowGavin George Credits/Source: Journal of
the International AIDS Society 2009, 12:18

Weighing costs, benefits of HIV treatments
Bio-Medicine – Tue, 15 Sep 2009 22:31
Weighing costs, benefits of HIV treatments
News Guide – Tue, 15 Sep 2009 16:17
Weighing costs, benefits of HIV treatments
EurekAlert! – Tue, 15 Sep 2009 16:09
Weighing costs, benefits of HIV treatments
Genetic Engineering & Biotechnology News – Tue, 15 Sep 2009 16:08
Weighing costs, benefits of HIV treatments
PhysOrg.com – Tue, 15 Sep 2009 15:54
Weighing costs, benefits of HIV treatments
First Science – Tue, 15 Sep 2009 08:46
Weighing costs, benefits of HIV treatments
e! Science News – Mon, 14 Sep 2009 16:12
Weighing costs, benefits of HIV treatments
Bright Surf – Wed, 16 Sep 2009 15:24
HIV Treatments: Weighing The Costs And Benefits
Medical News Today – Wed, 16 Sep 2009 12:51
HIV Treatments: Weighing The Costs And Benefits
MediLexicon – Wed, 16 Sep 2009 16:35
HANOVER, NH Prevention versus treatment? Cost versus efficacy? So go two of the dilemmas looming over
Dartmouth's Paul E. Palumbo, M.D., and his fellow researchers in the race to fight HIV and other infectious
diseases in the developing world especially among women and their young children.
...at the inaugural International Workshop on HIV Pediatrics and the International AIDS Society's fifth
Conference on HIV Pathogenesis Treatment...

Science, Politics, and the Presidential Aids ‘Cure’
Oxford Journals - African Affairs – Wed, 16 Sep 2009 20:29
2 ‘UN: no evidence for Gambian AIDS "cure" ’, United Press International, 16 March 2007,
http://www.aegis.com/news/upi/2007/UPI070330.html (4 April 2008).
...misinterpretation of the lab findings. In a statement released through the International AIDS Society and
the Society for AIDS in Africa, the scientist...

Boehringer: Head-to-head trial demonstrates Viramune’s similar efficacy and more favourable effect
on lipid profile compared to Atazanavir/Ritonavir
BioValley Basel - The Life Sciences Network – Thu, 17 Sep 2009 10:39
About Boehringer Ingelheim The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical
companies. Headquartered in Ingelheim, Germany, it operates globally with 138 affiliates in 47 countries and
41,300 employees.
...TOWN/South Africa Results from the ARTEN* trial presented at the 5th International AIDS Society (IAS)
conference in Cape Town, South Africa demonstrated...

GSK's second integrase inhibitor looks potent and well-tolerated in early study
Aidsmap – Thu, 17 Sep 2009 14:58
The experimental integrase inhibitor S/GSK1265744, which is being developed as a backup to
S/GSK1349572 (GSK-572), also demonstrated high potency and good tolerability in early studies,
researchers reported this week at the 49th Interscience Conference on Antimicrobial Agents and
Chemotherapy (ICAAC) in San Francisco.
...and Chemotherapy (ICAAC) in San Francisco. At the International AIDS Society meeting this past July,
researchers from GlaxoSmithKline and Shionogi...

World Congress on HD
We Are HD.org – Thu, 17 Sep 2009 22:16
Here are my notes from the Congress! The first points are KEY to the NYA. The rest is the boring stuff with
randomness (not very professional, but still kind of fun) thrown in.
...of BC Centre for Excellence on HIV/AIDS and president of the International AIDS Society- Amazing
presenter. HIV went from a death sentence to...

Southern Africa: HIV-positive children living longer
AEGiS – Sat, 19 Sep 2009 05:21
JOHANNESBURG, 18 September 2009 (PlusNews) - The number of HIV-infected children in southern Africa
who survive into adolescence without treatment is greater than previously thought, and will keep increasing
for years to come.
...in the September 24 issue of AIDS, the journal of the International AIDS Society. Previously, it was
assumed that few children who contracted...

Clinical presentation and aetiologies of acute or complicated headache among HIV-seropositive
patients in a Ugandan clinic
7thSpace – Sat, 19 Sep 2009 14:05
We set out to define the relative prevalence and common presentations of the various aetiologies of
headache within an ambulant HIV-seropositive adult population in Kampala, Uganda.
...SandeAllan RonaldElly KatabiraEdward WereJoris MentenRobert Colebunders Credits/Source: Journal of
the International AIDS Society 2009, 12:21

MSF har succes med behandling af aids-syge børn
Medecins Sans Frontieres – Sun, 20 Sep 2009 15:01
Læger uden Grænser (MSF) behandler med stor succes børn, som har hiv/aids, viser en undersøgelse, som
i aften i Rio de Janeiro bliver offentliggjort på International AIDS Society´s 3. konference. MSF´s kliniske
resultater er gode på trods af det faktum, at de nuværende eksisterende testmetoder og lægemidler er
dårligt tilpasset til børn.
...en undersøgelse, som i aften i Rio de Janeiro bliver offentliggjort på International AIDS Society´s 3.
konference. MSF´s kliniske resultater...

International AIDS Society – Press Clippings, 16-30 September 2009 2

Clinical presentation and aetiologies of acute or complicated headache amongHIV-seropositive
patients in a Ugandan clinic
7thSpace – Mon, 21 Sep 2009 12:26
We set out to define the relative prevalence and common presentations of the various aetiologies of
headache within an ambulant HIV-seropositive adult population in Kampala, Uganda.
...SandeAllan RonaldElly KatabiraEdward WereJoris MentenRobert Colebunders Credits/Source: Journal of
the International AIDS Society 2009, 12:21

EMEA APROVA INDICAÇÃO DO ANTI-RETROVIRAL RALTEGRAVIR PARA PACIENTES
SOROPOSITIVOS NUNCA ANTES TRATADOS
Maxpress – Tue, 22 Sep 2009 20:45
O EMEA (Agência de Medicamentos da União Européia) acaba de aprovar a ampliação do uso do anti-
retroviral raltegravir para pacientes soropositivos que nunca se submeteram antes a tratamento contra
AIDS.
...participantes). Um dos estudos, divulgado na Conferência da Sociedade Internacional de AIDS (IAS), em
Cape Town, África do Sul, revelou que a...

CCP,Heye begleitet Life Ball 2010
Der Standard – Wed, 23 Sep 2009 11:29
"Wir müssen es schaffen, die eigentliche Mission des Life Ball wieder in den Vordergrund zu stellen" Nach
einem Screening der Agenturszene haben sich Gery Keszler und sein Team entschlossen, CCP,Heye mit
der kommunikativen Begleitung des Life Ball 2010 zu beauftragen.
...2010 findet am 17. Juli 2010 statt und wird den Auftakt der der XVIII International AIDS Conference
(AIDS 2010), die vom 18. bis zum 23. Juli...

AFRIQUE AUSTRALE: Les enfants séropositifs vivent plus longtemps
PlusNews – Wed, 23 Sep 2009 17:05
(PlusNews) - En Afrique australe, le nombre d’enfants séropositifs qui survivent sans traitement jusqu’à
l’adolescence est plus important que ce qui avait été précédemment estimé, et devrait continuer à
augmenter au cours des années à venir.
...dans le numéro daté du 24 septembre d AIDS, la revue de l International AIDS Society. Auparavant, il
était estimé que les enfants à qui le VIH...

Audio: Some apples from the 'teacher'
Good As You – Wed, 23 Sep 2009 17:25
We've dug up some more audible nuggets from Stand For Marriage Maine's latest video star, Charla
Bansley, which even more fully detail how ridiculous it is for the "Yes" campaign to to refer to Ms.
...anti-gay rhetoric this are statistics published in Journal of the International AIDS Society. England
adopted same sex marriage in 2005 and in...

German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008
International Association of Journalists – Wed, 23 Sep 2009 22:20
GÃ RLITZ, Germany, November 28 /PRNewswire/ -- - "CyFlow" From Partec Expands Leadership in
Developing and Emerging Countries German biotech company Partec is expanding its global leadership in
specialized HIV monitoring and AIDS patient follow-up diagnostics for developing and emerging countries.
..."CyFlow" device will be placed since introduction at the XVI. International AIDS Conference in Barcelona
in July 2002. By precisely measuring the...

Abbott Study Shows Investigational Heat-Stable Norvir(R) Tablet Provides Similar Drug Levels to
Current Norvir Capsule
International Association of Journalists – Wed, 23 Sep 2009 22:26
MEXICO CITY, August 7 /PRNewswire/ -- - Pivotal Study of Norvir Tablet Bioavailability Will Form the Basis
of Request for Priority Regulatory Review Abbott (NYSE: ABT) presented pivotal data at the XVII
International AIDS Conference (AIDS 2008) in Mexico City today showing that its investigational Norvir(R)
(ritonavir) tablet and the current soft-gelatin capsule provide similar levels of drug in the blood.
...Regulatory Review Abbott (NYSE: ABT) presented pivotal data at the XVII International AIDS
Conference (AIDS 2008) in Mexico City today showing that...

International AIDS Society – Press Clippings, 16-30 September 2009 3

TMC278 Demonstrates Long-Term Efficacy and Tolerability in Treatment-Naïve Adults With HIV
International Association of Journalists – Wed, 23 Sep 2009 22:26
MEXICO CITY, Mexico, August 5 /PRNewswire/ -- - Ninety-Six-Week Data on Tibotec Investigational NNRTI
Presented at AIDS 2008 New phase IIb data from Tibotec Pharmaceuticals Ltd.
...HIV RNA copies/mL). These findings were presented today at the International AIDS Conference (AIDS
2008) in Mexico City. "The phase IIb data...

Deporting HIV-Positive Migrants Threatens Lives, Global Goals
Media For Freedom – Wed, 23 Sep 2009 22:49
Deporting HIV-Positive Migrants Threatens Lives, Global Goals Need to Ensure Continuity of Treatment and
Care Across Borders (London, September 24, 2009) National governments, in cooperation with international
agencies and donors, should reconsider deportation policies for people living with HIV/AIDS, four HIV/AIDS
and human rights groups said in a report released today.
...Foreigners: HIV-Related Restrictions on Entry, Stay, and Residence, Journal of the International AIDS
Society, 2008, at: http://www.jiasociety.org/content/11/1/8

Eine große Hoffnung
Maerkische Oderzeitung – Wed, 23 Sep 2009 23:09
Von Ina Matthes Auf der Welt-Aids-Konferenz vor einem Jahr in Mexiko zogen Wissenschaftler eine
ernüchternde Bilanz: Jahrzehntelange Forschung an einem Impfstoff war erfolglos geblieben.
Eine große Hoffnung Von Ina Matthes Auf der Welt-Aids-Konferenz vor einem Jahr in Mexiko zogen
Wissenschaftler eine ernüchternde Bilanz: Jahrzehntelange...

Leading HIV Experts Convene to Tackle the Challenge of Late Presentation in Europe
International Association of Journalists – Thu, 24 Sep 2009 00:01
LONDON, March 31 /PRNewswire/ -- - A third of HIV-infected persons in UK do not present for screening
and treatment until late in infection increasing morbidity and decreasing their quality of life.
...350-500 cells/mm3.(9,10) The 2008 International AIDS Society (IAS) treatment supports new data and
considerations for initiating therapy before...

South Africa: AHF to Launch New State-of-the-Art Free AIDS Treatment Clinic Location in Umlazi
International Association of Journalists – Thu, 24 Sep 2009 00:01
DURBAN, South Africa, March 28 /PRNewswire/ -- - After Seven Years of Growth, Ithembalabantu 'People's
Hope' AIDS Clinic Moves to New, Larger Freestanding Site at Umlazi's Ithala Centre.
...Africa In July 2000, AHF president Michael Weinstein attended the XIII International AIDS Conference in
Durban, South Africa, which for a brief...

SA tests Aids vaccine
Cape Argus – Sun, 20 Sep 2009 07:12
SA tests Aids vaccine
Daily News – Thu, 24 Sep 2009 09:45
Cape Town, South Africa - South Africa is launching clinical trials of the first Aids vaccines created by a
developing country, a feat by scientists who forged ahead even when some of their political leaders shocked
the world with unscientific pronouncements about the disease.
...problem" in the world, Mbewu said on the sidelines of an international Aids conference in Cape Town.
"Every emerging country is trying, wants...

Abschiebung von HIV-positiven Migranten gefährdet Menschenleben und weltweite
Entwicklungsziele
DailyNet.de – Thu, 24 Sep 2009 15:00
Abschiebung von HIV-positiven Migranten gefährdet Menschenleben und weltweite Entwicklungsziele Eine
kontinuierliche Behandlung und Versorgung muss auch über Grenzen hinweg sichergestellt sein (London,
24.
...Foreigners: HIV-Related Restrictions on Entry, Stay, and Residence , Journal of the International AIDS
Society, 2008: http://www.jiasociety.org/content/11/1/8

International AIDS Society – Press Clippings, 16-30 September 2009 4

A huge boost in the battle for HIV vaccine; 16,400 test subjects for HIV vaccine 8,197 subjects
vaccinated 8,198 subjects given a placebo 31 per cent efficiency rate It all adds up to ...
Hotels Magazine – Fri, 25 Sep 2009 13:29
TU THANH HA It worked only on two strains of a highly mutable virus, yielded modest results and is
nowhere near commercial licensing. But the first successful trial of an HIV vaccine has given a huge boost to
scientists seeking to inoculate humankind against the virus linked to AIDS.
...various candidate vaccines," said Julio Montaner, president of the International AIDS Society and
director of the B.C. Centre for Excellence...

Uganda: Why Simple Scientific Data is Hard to Come By
allAfrica.com: Kenya – Mon, 28 Sep 2009 11:01
Why Simple Scientific Data is Hard to Come By
Individual.com – Tue, 29 Sep 2009 12:57
Nairobi — Dr Mohammed Lamorde was anxious to have the survey results quickly translated and
disseminated to the traditional medical practitioners who had been part of his research.
...???? Wendo was one of the 1,500 journalists who covered the XIV International Aids Conference that
was held in Barcelona, Spain in May 2002. At...

ANALYSIS - AIDS vaccine works, but back to the drawing board
The Star Online - Malaysia News – Mon, 28 Sep 2009 20:08
By Maggie Fox, Health and Science Editor WASHINGTON (Reuters) - More than 25 years into the AIDS
pandemic, scientists finally have a vaccine that protects some people -- but instead of celebrating, they are
going back to the drawing board.
...poster with an AIDS red ribbon at the global village during the XVII International AIDS Conference in
Mexico City in this August 6, 2008 file...

Welt-Aids-Konferenz fordert billigere Medikamente
Pressemitteilung – Tue, 29 Sep 2009 09:15
09:59. Auf der Welt-Aids-Konferenz 2008 in Mexiko-Stadt fanden zwar Probleme in Bezug auf die Krankheit
Gehör, bis zur Lösung ist es aber noch ein weiter Weg.
Welt-Aids-Konferenz fordert billigere Medikamente 09:59. Auf der Welt-Aids-Konferenz 2008 in Mexiko-
Stadt fanden zwar Probleme in Bezug auf die...

A model for extending antiretroviral care beyond the rural health center
7thSpace – Tue, 29 Sep 2009 17:14
A major obstacle facing many lower income countries in establishing and maintaining HIV treatment
programs is the scarcity of trained health care providers.
...KemboiLillian BoitViola JebetAaron CarrollWilliam TierneySylvester Kimaiyo Credits/Source: Journal of the
International AIDS Society 2009, 12:22

ICAAC 2009: studies confirm the benefits of early initiation of therapy for HIV
Hotels Magazine – Tue, 29 Sep 2009 20:20
September 29, 2009 Back to Document List ICAAC 2009: studies confirm the benefits of early initiation of
therapy for HIV
...the US' Department of Health and Human Services (DHHS), the International AIDS Society (IAS) and the
British HIV Association (BHIVA) recommend...

VIH-SIDA : maintenir l'effort
Yahoo News (FR) – Wed, 30 Sep 2009 09:58
VIH-SIDA : maintenir l’effort
Destination Sante – Wed, 30 Sep 2009 12:01
Rendu public ce matin par l'OMS, l'UNICEF et l'ONUSIDA, le dernier rapport de situation sur le VIH-SIDA est
en demi-teinte. Il existe certes des progrès notables dans l'accès aux soins. En Afrique subsaharienne, 2,9
millions de patients séropositifs ont suivi un traitement antirétroviral en 2008, au lieu de seulement 2,1
millions en 2007.
...d'une voix commune par les 5 000 participants à la 5ème Conférence de l'International AIDS Society
(IAS), fin juillet au Cap, en Afrique du Sud.

International AIDS Society – Press Clippings, 16-30 September 2009 5